TY - JOUR
T1 - Hepatic resection for local recurrence after radiofrequency ablation therapy for colorectal liver metastases
AU - Iwamura, Sena
AU - Iida, Taku
AU - Terajima, Hiroaki
AU - Matsubara, Hiroyuki
AU - Goto, Toru
AU - Inoue, Yoshikage
AU - Yoshitomi, Mami
AU - Uchida, Yoichiro
AU - Ueda, Shugo
AU - Kanazawa, Akiyoshi
PY - 2014/11
Y1 - 2014/11
N2 - Patients who underwent hepatic resection of locally recurrent tumors after radiofrequency ablation (RFA) for colorectal liver metastases (CRLM) were retrospectively investigated. Among 12 patients who underwent RFA as first-line treatment for CRLM, 7 experienced local recurrence, 5 of whom (6 nodules) underwent hepatic resection. The mean diameter (range) of the tumors was 9.5 (5-16) mm, and they were located at S2, S7 (adjacent to the right hepatic vein), S5/6 (between the root of the anterior and the posterior Glisson's pedicle), S1r (right paracaval portion), S6, and S3. No local recurrence was observed after hepatic resection. In conclusion, hepatic resection must be the initial therapeutic strategy for CRLM, and the indication for RFA must be considered carefully.
AB - Patients who underwent hepatic resection of locally recurrent tumors after radiofrequency ablation (RFA) for colorectal liver metastases (CRLM) were retrospectively investigated. Among 12 patients who underwent RFA as first-line treatment for CRLM, 7 experienced local recurrence, 5 of whom (6 nodules) underwent hepatic resection. The mean diameter (range) of the tumors was 9.5 (5-16) mm, and they were located at S2, S7 (adjacent to the right hepatic vein), S5/6 (between the root of the anterior and the posterior Glisson's pedicle), S1r (right paracaval portion), S6, and S3. No local recurrence was observed after hepatic resection. In conclusion, hepatic resection must be the initial therapeutic strategy for CRLM, and the indication for RFA must be considered carefully.
UR - http://www.scopus.com/inward/record.url?scp=84949194505&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84949194505&partnerID=8YFLogxK
M3 - Article
C2 - 25731423
AN - SCOPUS:84949194505
VL - 41
SP - 2062
EP - 2064
JO - Japanese Journal of Cancer and Chemotherapy
JF - Japanese Journal of Cancer and Chemotherapy
SN - 0385-0684
IS - 12
ER -